CDK16 as a potential prognostic biomarker correlated with an immunosuppressive tumor microenvironment and benefits in enhancing the effectiveness of immunotherapy in human cancers
Figure 4.Prognostic value of CDK16. Forest plots showing results of univariate Cox regression analysis for (A) DSS, (B) DFI, and (C) PFI. Red color represents significant results (p < 0.05).